Featured News

JAMA Network

nference and Mayo Clinic Study Confirms Efficacy of Ad26.COV2.S Vaccine in Reducing COVID-19 Infections

EHR data verifies the Ad26.COV2.S vaccine – known publicly as the Johnson and Johnson COVID-19 vaccine – was over 73 percent effective against SARS-CoV-2 infections during the first five months after initial rollout.....

November 2 2021

JAMA Network

November 2 2021

nference and Mayo Clinic Study Confirms Efficacy of Ad26.COV2.S Vaccine in Reducing COVID-19 Infections

EHR data verifies the Ad26.COV2.S vaccine – known publicly as the Johnson and Johnson COVID-19 vaccine – was over 73 percent effective against SARS-Co....

Press Release

Read more ->

Sorted by Most Recent
All Topics

Media Contact | media@nference.net

of 0

Let’s talk about how we can work together.

Fill out the form and we’ll get right back to you.

Let’s talk ->

@2021 nference, Inc. All rights reserved.